search
Back to results

Effect of RIC on BP and Inflammatory Response in Women With Pre-eclampsia

Primary Purpose

Pre-Eclampsia; Mild, Gestational Hypertension

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Remote Ischaemic Conditioning (RIC)
Sponsored by
University of Aarhus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pre-Eclampsia; Mild focused on measuring Pre-Eclampsia; Mild, Pre-Eclampsia; Moderate, Gestational Hypertension, Remote ischemic conditioning

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Systolic blood pressure above 140 and/or
  • Diastolic blood pressure above 85
  • Proteinuria +/-
  • Clinical signs / symptoms +/-

Clinical signs and symptoms of pre-eclampsia +/-

Exclusion Criteria:

• Eclampsia

Sites / Locations

  • Aarhus University hospital
  • Herning Hospital
  • Randers Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

RIC

Arm Description

RIC treatment arm The CellAegis auto RIC (automated blood pressure cuff) will be placed on the upper arm and inflated to 200 mmHg for 5 minutes followed by 5 minutes of deflation. The programmed cycle is repeated 4 times in total, summing up to a total treatment length of 35 minutes. The treatment will be carried out on the morning of day 2 to day 7 by the participants themselves at their home.

Outcomes

Primary Outcome Measures

Median arterial blood pressure
Median arterial blood pressure after 6 days of treatment

Secondary Outcome Measures

The inflammatory response
Changes in the inflammatory response after 6 days of treatment
Medication
prescription of antihypertensive

Full Information

First Posted
October 24, 2017
Last Updated
January 4, 2021
Sponsor
University of Aarhus
Collaborators
Randers Regional Hospital, Herning Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03323762
Brief Title
Effect of RIC on BP and Inflammatory Response in Women With Pre-eclampsia
Official Title
Effect of Remote Ischemic Conditioning on Blood Pressure and Inflammatory Response in Women With Pre-eclampsia and Gestational Hypertension
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
October 24, 2017 (Actual)
Primary Completion Date
August 28, 2020 (Actual)
Study Completion Date
August 28, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus
Collaborators
Randers Regional Hospital, Herning Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this pilot cohort study is to investigate whether treatment with remote ischemic conditioning (RIC) has a beneficial effect on blood pressure as well as the immune system in pregnant women with newly diagnosed hypertension (> 140/58 mm Hg) or pre-eclampsia before gestational week 37+3.
Detailed Description
Pre-eclampsia, which affects about 2 to 7% of pregnancies, is a major cause of maternal and perinatal morbidity and mortality. The onset of clinical symptoms (hypertension, proteinuria or end- organ dysfunction), are often seen in the last trimester of a pregnancy. The disease can have major consequences for both the child and the mother. Yet there are only very limited treatment options, where induced labour is the only healing treatment. Today, the treatment consists in limiting blood pressure increase with medical treatment, whereby the pregnancy most often can result in term delivery. Remote Ischaemic Conditioning (RIC) achieved by an automatic inflation of a blood pressure cuff to induce four 5-minute cycles of limb ischaemia and reperfusion, is a treatment that has been found to decrease the inflammatory response and lower blood pressure in states of myocardial infarction, chronic heart failure, and stroke. The treatment is virtually a cost-free non-pharmacological and non-invasive therapeutic strategy performed by the patient herself in her home. However, whether RIC actually can improve clinical outcomes in relation to lowering blood pressure and the inflammatory response in pregnant women with newly diagnosed hypertension is yet to be investigated. Aim and endpoint: The aim of this pilot cohort study is to investigate whether treatment with remote ischemic conditioning (RIC) has a beneficial effect on blood pressure as well as the immune system in pregnant women with newly diagnosed hypertension (> 140/58mm Hg) or pre-eclampsia before gestational week 37+3. Primary end-point • Median arterial blood pressure after 6 days of treatment Secondary end-point • Changes in the inflammatory response Design and method: In a pilot cohort study at Aarhus University Hospital, Regional Hospital Randers and Region Hospital Herning 20 pregnant women with signs of gestational hypertension or pre-eclampsia (systolic blood pressure above 140 and / or diastolic blood pressure over 85; +/- proteinuria, +/- clinical signs or subjective symptoms and signs) are to be enrolled. The study flowchart: Newly hospital referred women with signs of gestational hypertension or pre-eclampsia will be asked to participate. Informed consent will be obtained and blood pressure, blood samples, and weight will be measured. Day 1: resting day at home - blood pressure measuring Day 2-7: Morning: Blood pressure measuring and RIC treatment. Evening: blood pressure measuring Day 7: In hospital: Blood samples and weight will be measured. Pros and cons: In relation to the inflation of the blood pressure cuff temporary moderate pains in the treated arm might occur. Otherwise, the RIC is without side effects. Two extra blood samples of app. 50 ml each will be drawn, with a small risk of local infection exist. The usefulness of the study The study is designed as a small pilot study. In which the set up will be tested and the effects on blood pressure and the inflammatory response in a relative small size will be explored. A larger randomised study will follow if the results show a positive trend. Positive as well as negative and inconclusive results will be widely disseminated through national and international scientific journals and conferences.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pre-Eclampsia; Mild, Gestational Hypertension
Keywords
Pre-Eclampsia; Mild, Pre-Eclampsia; Moderate, Gestational Hypertension, Remote ischemic conditioning

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
RIC
Arm Type
Experimental
Arm Description
RIC treatment arm The CellAegis auto RIC (automated blood pressure cuff) will be placed on the upper arm and inflated to 200 mmHg for 5 minutes followed by 5 minutes of deflation. The programmed cycle is repeated 4 times in total, summing up to a total treatment length of 35 minutes. The treatment will be carried out on the morning of day 2 to day 7 by the participants themselves at their home.
Intervention Type
Device
Intervention Name(s)
Remote Ischaemic Conditioning (RIC)
Intervention Description
The CellAegis auto RIC (automated blood pressure cuff) will be placed on the upper arm and inflated to 200 mmHg for 5 minutes followed by 5 minutes of deflation. The programmed cycle is repeated 4 times in total, summing up to a total treatment length of 35 minutes
Primary Outcome Measure Information:
Title
Median arterial blood pressure
Description
Median arterial blood pressure after 6 days of treatment
Time Frame
after 6 days of treatment
Secondary Outcome Measure Information:
Title
The inflammatory response
Description
Changes in the inflammatory response after 6 days of treatment
Time Frame
after 6 days of treatment
Title
Medication
Description
prescription of antihypertensive
Time Frame
After 6 days of treatment

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Obs pre-eclampsia
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Systolic blood pressure above 140 and/or Diastolic blood pressure above 85 Proteinuria +/- Clinical signs / symptoms +/- Clinical signs and symptoms of pre-eclampsia +/- Exclusion Criteria: • Eclampsia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ulla Kristine Møller Liendgaard, Phd, MHSc.
Organizational Affiliation
Aarhus University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aarhus University hospital
City
Aarhus
ZIP/Postal Code
8200
Country
Denmark
Facility Name
Herning Hospital
City
Herning
ZIP/Postal Code
7400
Country
Denmark
Facility Name
Randers Hospital
City
Randers
ZIP/Postal Code
8930
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effect of RIC on BP and Inflammatory Response in Women With Pre-eclampsia

We'll reach out to this number within 24 hrs